Heart drug trial halted before it began: no patients enrolled
NCT ID NCT04306237
First seen Nov 11, 2025 · Last updated Apr 28, 2026 · Updated 21 times
Summary
This study was designed to test a new drug, IMB-1018972, in people with refractory angina—chest pain that doesn't improve with standard treatments. The goal was to see if the drug could safely help patients exercise longer and have fewer angina episodes. However, the trial was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY ANGINA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Imbria Investigational Site
Boston, Massachusetts, 02110, United States
Conditions
Explore the condition pages connected to this study.